Blackbaud, Inc. (BLKB) News
Filter BLKB News Items
BLKB News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BLKB News Highlights
- BLKB's 30 day story count now stands at 7.
- Over the past 28 days, the trend for BLKB's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- ANSS, DRUG and FAT are the most mentioned tickers in articles about BLKB.
Latest BLKB News From Around the Web
Below are the latest news stories about BLACKBAUD INC that investors may wish to consider to help them evaluate BLKB as an investment opportunity.
A Look At The Intrinsic Value Of Blackbaud, Inc. (NASDAQ:BLKB)Key Insights The projected fair value for Blackbaud is US$85.42 based on 2 Stage Free Cash Flow to Equity Current share... |
America Ferrera Will Join the Mainstage at Blackbaud's bbcon 2023 Tech ConferenceBlackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, today announced that America Ferrera will join the mainstage for a keynote conversation at bbcon 2023, Blackbaud's annual tech conference. bbcon will be back live this year, October 22-24 in Denver, Colorado. |
Ansys (ANSS) Up 4.4% Since Last Earnings Report: Can It Continue?Ansys (ANSS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Truth Initiative and EVERFI Collaborate to Launch Updated Prescription Drug Safety Curriculum for Middle and High School Students Amid Growing Youth Overdose CrisisTruth Initiative, the organization behind truth®, the nationally recognized, proven-effective youth tobacco and opioid prevention public education campaigns, and EVERFI® from Blackbaud®, the leader in powering social impact through education, have joined forces once again to address prescription drug safety, with two new lessons, including one that specifically addresses the growing fentanyl overdose crisis among young people. A potent synthetic opioid, fentanyl has become a leading cause of fat |
Why Is Blackbaud (BLKB) Up 1% Since Last Earnings Report?Blackbaud (BLKB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Blackbaud Customers Raise Millions of Dollars for Victims of the Hawaii WildfiresBlackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, is sharing how its customers are creating incredible impact by raising funds and providing disaster relief for the people of Hawaii in the wake of catastrophic wildfires, including the Lahaina fire on Maui, the deadliest U.S. wildfire in the last century. |
JustGiving to Revolutionize Fundraising with the Integration of Generative AIBlackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, today announced a groundbreaking AI development for JustGiving®, the world's most trusted platform for online giving. Through generative AI, fundraisers on JustGiving are now able to quickly and easily create personal stories to share with their networks. This update is expected to benefit more than 20,000 charities, as part of Blackbaud's Intelligence for Good® strategy. |
Blackbaud Names Todd Lant Chief Customer OfficerBlackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, today appointed Todd Lant chief customer officer. Lant has been with Blackbaud for 20 years, most recently serving as chief information officer and leading the global customer success team as interim director over the past several months. |
Blackbaud (BLKB) Q2 Earnings Top Estimates, Revenues Up Y/YBlackbaud's (BLKB) second-quarter 2023 revenues benefit from increased recurring revenues. |
Blackbaud (BLKB) Q2 Earnings Surpass EstimatesBlackbaud (BLKB) delivered earnings and revenue surprises of 5.38% and 0.59%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? |